Goodman WK - Search Results

1

A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.

Storch EA, Murphy TK, Goodman WK, Geffken GR, Lewin AB, Henin A, Micco JA, Sprich S, Wilhelm S, Bengtson M, Geller DA. Storch EA, et al. Among authors: goodman wk. Biol Psychiatry. 2010 Dec 1;68(11):1073-6. doi: 10.1016/j.biopsych.2010.07.015. Biol Psychiatry. 2010. PMID: 20817153 Free PMC article. Clinical Trial.

2

Current treatment approaches to obsessive-compulsive disorder.

Boyarsky BK, Perone LA, Lee NC, Goodman WK. Boyarsky BK, et al. Among authors: goodman wk. Arch Psychiatr Nurs. 1991 Oct;5(5):299-306. doi: 10.1016/0883-9417(91)90028-4. Arch Psychiatr Nurs. 1991. PMID: 1750780 Free article.

3

A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.

McDougle CJ, Price LH, Goodman WK, Charney DS, Heninger GR. McDougle CJ, et al. Among authors: goodman wk. J Clin Psychopharmacol. 1991 Jun;11(3):175-84. J Clin Psychopharmacol. 1991. PMID: 1820757 Clinical Trial.

4

Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.

McDougle CJ, Goodman WK, Price LH, Delgado PL, Krystal JH, Charney DS, Heninger GR. McDougle CJ, et al. Among authors: goodman wk. Am J Psychiatry. 1990 May;147(5):652-4. doi: 10.1176/ajp.147.5.652. Am J Psychiatry. 1990. PMID: 1970224

5

Cerebral laterality, perception of emotion, and treatment response in obsessive-compulsive disorder.

Wexler BE, Goodman WK. Wexler BE, et al. Among authors: goodman wk. Biol Psychiatry. 1991 May 1;29(9):900-8. doi: 10.1016/0006-3223(91)90056-r. Biol Psychiatry. 1991. PMID: 2049488 Free article.

6

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.

Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS. Goodman WK, et al. Arch Gen Psychiatry. 1990 Jun;47(6):577-85. doi: 10.1001/archpsyc.1990.01810180077011. Arch Gen Psychiatry. 1990. PMID: 2112374 Clinical Trial.

7

Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?

Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF. Goodman WK, et al. J Clin Psychiatry. 1990 Aug;51 Suppl:36-43; discussion 55-8. J Clin Psychiatry. 1990. PMID: 2199433 Review.

8

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.

Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS. Goodman WK, et al. Arch Gen Psychiatry. 1989 Jan;46(1):36-44. doi: 10.1001/archpsyc.1989.01810010038006. Arch Gen Psychiatry. 1989. PMID: 2491940 Clinical Trial.

9

The Yale-Brown Obsessive Compulsive Scale. II. Validity.

Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. Goodman WK, et al. Arch Gen Psychiatry. 1989 Nov;46(11):1012-6. doi: 10.1001/archpsyc.1989.01810110054008. Arch Gen Psychiatry. 1989. PMID: 2510699

10

Treatment of severe obsessive-compulsive disorder with fluvoxamine.

Price LH, Goodman WK, Charney DS, Rasmussen SA, Heninger GR. Price LH, et al. Among authors: goodman wk. Am J Psychiatry. 1987 Aug;144(8):1059-61. doi: 10.1176/ajp.144.8.1059. Am J Psychiatry. 1987. PMID: 3111279 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

385 results

Search Page

Filters